CL Colgate-Palmolive
Durable oral-care moat, but even a normalized 20% margin leaves the stock priced for perfection.
The story
Colgate-Palmolive is a mature global staples franchise built on Colgate's roughly 40% share of the world toothpaste market and Hill's premium pet nutrition. Its brand and distribution moat is durable, especially in emerging markets, which bring in about 45% of sales. Organic growth has slowed to the low single digits as pricing power fades and volumes stay soft. Reported margins have fallen from 21.1% to 15.2% TTM, mostly because of restructuring and impairment charges, not because the underlying franchise has eroded.
Growth, sales-to-capital and horizon stay where they were: TTM growth is 3.3%, the business still needs little capital, and its maturity has not changed. I raised the target margin to 20.5% (+8%, not material) because the drop to 15.2% looks like one-off charges against an adjusted run-rate of about 21%. I trimmed beta to 0.65 because the business is defensive. Terminal growth moves from 2.0% to 2.5% (+25%, material) because the large emerging-market mix supports nominal growth near inflation. Together these narrow, but do not close, the large gap to the market price.
Value drivers
| Revenue growth (Y1) | 3.5% |
| Terminal growth | 2.5% |
| Forecast horizon | 7y |
| Target operating margin | 20.5% |
| Years to target margin | 4 |
| Sales-to-capital | 2.62 |
| Beta | 0.65 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 7.6% |
| Terminal WACC | 9.0% |
Valuation bridge
| PV of explicit FCFF | 16.37B |
| PV of terminal value | 30.66B |
| Equity value | 40.02B |
| ÷ shares → per share | $50.20 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 21.78B | 3.5% | 16.5% | 2.66B | 281.15M | 2.38B | 2.21B |
| 2 | 22.51B | 3.3% | 17.8% | 2.97B | 277.13M | 2.69B | 2.32B |
| 3 | 23.22B | 3.2% | 19.2% | 3.29B | 272.05M | 3.02B | 2.42B |
| 4 | 23.92B | 3.0% | 20.5% | 3.62B | 265.89M | 3.36B | 2.50B |
| 5 | 24.60B | 2.8% | 20.5% | 3.73B | 258.66M | 3.47B | 2.40B |
| 6 | 25.25B | 2.7% | 20.5% | 3.83B | 250.34M | 3.58B | 2.30B |
| 7 | 25.88B | 2.5% | 20.5% | 3.92B | 240.95M | 3.68B | 2.20B |
Key risks
- Restructuring charges keep recurring and adjusted margins never get back to 20%+
- Emerging-market currency moves and falling volumes cut into dollar growth
- Private label and competition in premium pet food erode Hill's pricing
Catalysts
- Productivity program savings show up and push reported margins back toward 20%
- Volume-led organic growth returns in Latin America and Asia